MAGED2 and hepatocellular carcinoma: By contrast, increased expression levels of MAGE-D2 were significantly associated with earlier mortality following curative resection, indicating that the upregulation of MAGE-D2 contributed to the progression of HCC rather than to carcinogenesis.